| VERTEX PHARMACEUTICALS |
| USA |
| Gesundheit |
| US92532F1003 / 882807 |
| VX1 (Frankfurt) / VRTX (NASDAQ) |
| FRA:VX1, ETR:VX1, VX1:GR, NASDAQ:VRTX |
| https://www.vrtx.com/ |
|
Vertex Pharmaceuticals Inc. is a leading biotechno..
>Volltext.. |
| 92467.72 Mio. EUR |
| 88339.58 Mio. EUR |
| 9780.52 Mio. EUR |
| 3951.31 Mio. EUR |
| 3122.32 Mio. EUR |
| 12.13 EUR |
| 1311.04 Mio. EUR |
| 4276.28 Mio. EUR |
| 3301.55 Mio. EUR |
| 1.54 |
| 0.37% |
| - |
| - |
| - |
| - |
| VERTEX PHARMACEUTICALS, VERTEX PHARMA, VRTX |
| 30.10.25 |
|